Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Critical Reviews™ in Eukaryotic Gene Expression
IF: 1.841 5-Year IF: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN Print: 1045-4403
ISSN Online: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.2015013843
pages 203-207

Dual Protective and Cytotoxic Benefits of Mesenchymal Stem Cell Therapy in Combination with Chemotherapy/Radiotherapy for Cancer Patients

Fatemeh Hendijani
Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran
Shaghayegh Haghjooy Javanmard
Applied Physiology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

ABSTRACT

Cancer is a major health problem in the world, and scientists seek innovative treatment strategies with higher efficacy and lower toxicity than the existing therapeutic agents. In this way, stem cell researchers try to reveal new pathways that will eventually benefit patients. Stem cell research has proven that mesenchymal stem cells (MSCs) possess anticancer activities, and their protein-rich secretome showed similar effects. MSCs also secrete cytokines that play an active role in healing and regeneration processes. Because of their known plasticity, MSCs display a variety of characteristics and functions in different environments, depending on their interactions with various cell types and tissues. Therefore, we hypothesize that MSC therapy in combination with anticancer medicines can potentiate cytotoxic effects on cancer cells. In addition, because of their regenerative capacity, MSCs can protect normal tissues from adverse cytotoxic drug reactions. They may also help rescue injured tissues from these toxic damages or systemic pathological events that occur during cancer treatment. MSC therapy may double the beneficial effects on cancer and normal cells. As our knowledge of systems biology and biotechnological methodology is progressing, this idea can move forward as a treatment option.


Articles with similar content:

Human Mesenchymal Stem Cells in Cancer Therapy
Critical Reviews™ in Eukaryotic Gene Expression, Vol.26, 2016, issue 1
Rasime Kalkan, Nedime Serakinci
Programming hMSCs into Potential Genetic Therapy in Cancer
Critical Reviews™ in Eukaryotic Gene Expression, Vol.29, 2019, issue 4
Nedime Serakinci, Huseyin Cagsin
Mesenchymal Stem Cells and Their Immune Properties
International Journal of Physiology and Pathophysiology, Vol.5, 2014, issue 2
Mykola I. Lisianyi
Regenerative Dental Medicine: Stem Cells and Tissue Engineering in Dentistry
Journal of Environmental Pathology, Toxicology and Oncology, Vol.25, 2006, issue 3
Jill A. Reed, Roberto Patarca
Suspension Culture of Pluripotent Stem Cells: Effect of Shear on Stem Cell Fate
Critical Reviews™ in Eukaryotic Gene Expression, Vol.24, 2014, issue 1
Kevin C. Keller, Beatriz Rodrigues, Nicole I. zur Nieden